Journals / Ankara Üniversitesi Veteriner Fakültesi Dergisi / 2006 / Cilt: 53 - Sayı: 1

Ratlarda gentamisine bağlı oluşan nefrotoksisiteden korunmada allopurinolün etkisizliği

Unable to protect gentamicin-induced nephrotoxicity with allopurinol in rats

Pages
65–68
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, results demonstrate that allopurinol, a xanthine oxidase inhibitor, does not prevent the formation of gentamicin induced nephrotoxicosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, it is purposed to investigate the protective effects of allopurinol, a xanthine oxidase inhibitor, against gentamicin -induced nephrotoxicosis.
📊
Key Findings & Data:The levels of serum urea, creatinine and plasma MDA were significantly higher and GSH-Px, SOD activities were lower in gentamicin administrated group than the control.
💡
Conclusion & Impact:In conclusion, results demonstrate that allopurinol, a xanthine oxidase inhibitor, does not prevent the formation of gentamicin induced nephrotoxicosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, it is purposed to investigate the protective effects of allopurinol, a xanthine oxidase inhibitor, against gentamicin -induced nephrotoxicosis. The levels of serum urea, creatinine and plasma MDA were significantly higher and GSH-Px, SOD activities were lower in gentamicin administrated group than the control. The levels of serum urea, creatinine and plasma MDA were significantly higher and GSH-Px, SOD and CAT activities were significantly lower in gentamicin + allopurinol administrated group than the control. Plasma MDA was significantly lower and GSH-Px, SOD activities were higher in gentamicin induced group than gentamicin + allopurinol induced group. In conclusion, results demonstrate that allopurinol, a xanthine oxidase inhibitor, does not prevent the formation of gentamicin induced nephrotoxicosis.

Özet

Bu çalışmada, ksantin oksidaz inhibitörü olan allopurinolün gentamisin nefrotoksikozisinde koruyucu etkinliğinin araştırılması amaçlanmıştır. Gentamisin verilen grubun serum üre ve kreatinin düzeyleri ile plazma MDA düzeyi kontrol grubuna göre istatistiksel olarak önemli düzeyde yüksek bulunurken, eritrositlerde GSH-Px, SOD aktiviteleri düşük bulundu. Gentamisin+Allopurinol verilen grubun serum üre ve kreatinin düzeyleri ile plazma MDA düzeyi kontrol grubuna göre önemli düzeyde yüksek bulunurken, GSH-Px, SOD ve CAT aktiviteleri önemli düzeyde düşüktü. Gentamisin verilen grubun plazma MDA düzeyi gentamisin+allopurinol verilen gruba göre önemli düzeyde düşük iken GSH-Px, SOD aktiviteleri önemli düzeyde yüksekti. Sonuçta ksantin oksidaz inhibitörü olan allopurinolün gentamisin nefrotoksikozisinin oluşumunu önleyemediği kanısına varılmıştır.

🔖

Cite This Article

ULUTAŞ, B., BIRINCIOĞLU, S., KIRAL, F. (2022). Ratlarda gentamisine bağlı oluşan nefrotoksisiteden korunmada allopurinolün etkisizliği. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 53 - Sayı: 1, 65–68. https://ajindex.com/articles/445196

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ciz M, Cizova H, Lojek A, Kubala L, Papezikova I (2001): Ischemia/Reperfusion Injury of Rat Small Intestine: The Effect of Allopurinol Dosage. Transplant P, 33,2871-2873. 2.Culling CFA, Allison RA, Barr WT (1985): Cellular Pathology Technicgue. Mid-Country Press, London. 3.Diamond JR, Bonventre JV, Karnovsky MJ (1986): A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int, 29, 478-483. 4.Faure M, Lissi EA, Videla LA (1990): Antioxidant capacity of allopurinol in biological systems. Biochem Int, 21,357-366. 5.Greene EL, Paller MS (1991): Oxygen free radicals in acute renal failure. Miner Electrolyte Metab, 17, 124-132. 6.Hande K, Reede E, Chabner B (1978): Allopurinol Kinetics. Clin Pharmacol Ther, 23, 598-605. 7 Kavutcu M, Canbolat O, Öztürk S, Olcay E, Ulutepe S, Ekinci C, Gökhun IH, Durak I (1996): Reduced enzymatic antioxidant defence mechanism in kidney tissues from gentamicin-treated guine pigs: Effects of vitamin E and C. Nephron, 72, 269-274. 8.Kumar KV, Shifow AA, Naidu MUR, Ratnakar KS (2000): Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats. Life Sci, 66, 2603-2611. 9.Lack H (1965): Catalase. 855-884. In: HU Bergmeyer (Ed.), Methods in Analysis. Academic Press Inc, London. 10.Maestro RF (1980): An approach to free radicals in medicine and biology. Acta Physiol Scand, 492, 153. 11.Maxie MG, Prescott JF. ( 993): Urinary System. 487-491, In: KVF Jubb, PC Kennedy, N Palmer (Eds), Pathology of Domestic Animals. Academic Press, New York. 12.Paglia DE, Valentine WN (1967): Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med, 70, 158-169. 13.Richter C (1995): Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol, 27, 647-653. 14.Sun Y, Oberley LW, Li Y (1988): A simple for clinical assay of superoxide dismutase. Clin Chem, 34, 497-500. 15.Thiemermann C, Bowes J, Myint FP, Vane JR (1997): Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA, 94, 679-683. 16.Tietz WN (1987): Fundamental of Clinical Chemistry. WB Saunders Co. Philadelphia. 17.Wexler BC, Greenberg BP (1978): Allopurinol-induced myocardial and renal damage in nonarteriosclerotic (virgin) and arteriosclerotic (breeder) Sprague-Dawley rats. Proc Soc Exp Biol Med, 157, 541-549. 18.Whiting PH, Brown PA (1996): The re